Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

famotidine-ibuprofen

famotidine-ibuprofen
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Duexis TABLET, ORAL 26.6 mg-800 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

famotidine-ibuprofen (Duexis)

  • 26.6 mg-800 mg tablet oral TID

famotidine (Pepcid) AND ibuprofen (Advil, Motrin)

  • ONE 20 mg famotidine tablet oral PLUS ONE 800 mg ibuprofen tablet TID

Duexis medication guide

Duexis is non-formulary, not stocked. Dispense individual components separately. Interchange the famotidine 26.6 mg component to famotidine 20 mg.

If H2 blocker prescribed with PPO, discontinue H2 blocker after 48 hours. Exception if GI physician -- check with physician that H2 blocker is not being used for a non-GI use prior to discontinuing.

Reviewed: June 28, 2011

Last updated: Mar. 1, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved